Log In
Print this Print this

UNIchip AV-400

  Manage Alerts
Collapse Summary General Information
Company Protagen AG
DescriptionProtein biochip to aid antibody development
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationAutoimmune, Diagnostic
Indication DetailsTest off-target activity of tumor necrosis factor (TNF) drugs
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today